Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 16, 2025 | AllRock Bio Announces $50M Series A Round | NATICK, MA, AllRock Bio, a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, today announced a $50 million Series A round. >> Click here for more funding data on AllRock Bi... |
| Sep 16, 2025 | AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension | |
| AllRock Bio | “AllRock Bio is leveraging extensive expertise from drug development to commercialization. AllRock Bio’s team is dedicated to advancing impactful therapies for cardiopulmonary diseases.” |
Reviews 0
FAQ about AllRock Bio
What has the press written about AllRock Bio?
Parsers VC has collected 4 articles mentioning AllRock Bio, among them “AllRock Bio Announces $50M Series A Round” (Sep 16, 2025) and “AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension” (Sep 16, 2025).
Is AllRock Bio still active?
Yes, AllRock Bio is active; its latest activity on Parsers VC dates from Sep 17, 2025.